Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBOP/BEP versus BEP in poor prognosis male germ cell tumours
ISRCTN53643604Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Jun 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial of carboplatin, bleomycin, vincristine, cisplatin and etoposide in Non-Germinomatous Germ Cell Tumor (NGGCT) (2 arms), sponsored by Medical Research Council. Primary endpoint: Primary endpoint not provided. Started Jun 2005; status: completed.
02
Drugs
carboplatinbleomycinvincristinecisplatinetoposide
03
Conditions
Non-Germinomatous Germ Cell Tumor (NGGCT)
Beyond the preview
Go deeper on ISRCTN53643604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN53643604.